To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

No difference between PRP and lidocaine injection in addition to tenotomy for elbow tendinopathy

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
May 2019

No difference between PRP and lidocaine injection in addition to tenotomy for elbow tendinopathy

Vol: 8| Issue: 5| Number:27| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Platelet-rich plasma versus lidocaine as tenotomy adjuvants in people with elbow epicondylopathy: a randomized controlled trial

J Orthop Surg Res. 2019 Apr 23;14(1):109. doi: 10.1186/s13018-019-1153-6

Contributing Authors:
JI Martin L Atilano J Merino I Gonzalez G Iglesias L Areizaga P Bully G Grandes I Andia

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

80 patients with elbow tendinopathy and scheduled for needle tenotomy were randomized to adjuvant intratendinous injection or either platelet-rich plasma or lidocaine. Intratendinous injections were performed within areas of hypoechogenicity observed during ultrasound-guided tenotomy. Primary outcomes were the proportion of patients who demonstrated minimum reductions of 25% from baseline in the D...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue